DART-MS for rapid, preliminary screening of urine for DMAA

Drug Testing and Analysis

Volumn 6, Issue 7-8, 2014, Pages 788-796

  Lesiak, Ashton D ^a   Adams, Kendra J ^a   Domin, Marek A ^b   Henck, Colin ^a   Shepard, Jason R E ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b BOSTON COLLEGE   (United States)

Author keywords

Collision induced dissociation; DART MS; Direct analysis in real time mass spectrometry; DMAA; Natural supplements; Urine testing

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS;

COLLISION INDUCED DISSOCIATION; DIMETHYLAMYLAMINE; DIRECT ANALYSE IN REAL TIME MASS SPECTROMETRY; DIRECT ANALYSIS IN REAL-TIME; NATURAL SUPPLEMENT; REAL-TIME MASS SPECTROMETRY; URINE TESTING;

MASS SPECTROMETRY;

4 METHYL 2 HEXYLAMINE; 1,3-DIMETHYLAMYLAMINE; AMINE; ANOREXIGENIC AGENT;

ARTICLE; CHEMICAL ANALYSIS; COLLISIONALLY ACTIVATED DISSOCIATION; IONIZATION; MASS SPECTROMETRY; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS; ANALYSIS; DIET SUPPLEMENTATION; DOPING; ECONOMICS; HUMAN; PROCEDURES; SUBSTANCE ABUSE; TIME; URINE;

AMINES; APPETITE DEPRESSANTS; DIETARY SUPPLEMENTS; DOPING IN SPORTS; HUMANS; MASS SPECTROMETRY; SUBSTANCE ABUSE DETECTION; TIME FACTORS;

EID: 84904578883     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1540     Document Type: Article

References (56)

1. M.B. Forrester . Exposures to 1, 3-dimethylamylamine-containing products reported to Texas poison centers. Hum. Exp. Toxicol. 2013, 32, 18.
2. P. Gee, C. Tallon, N. Long, G. Moore, R. Boet, S. Jackson . Use of recreational drug 1, 3-dimethylethylamine (DMAA) associated with cerebral hemorrhage. Ann. Emerg. Med. 2012, 60, 431.
3. A. Lisi, N. Hasick, R. Kazlauskas, C. Goebel . Studies of methylhexaneamine in supplements and geranium oil. Drug Test. Anal. 2011, 3, 873.
4. S.P. Vorce, J.M. Holler, B.M. Cawrse, J. Magluilo . Dimethylamylamine: A drug causing positive immunoassay results for amphetamines. J. Anal. Toxicol. 2011, 35, 183.
5. WADA. Available at: http://www.wada-ama.org/Documents/World_Anti-Doping [26 April 2012].
6. M. Thevis, T. Kuuranne, H. Geyer, W. Schänzer . Annual banned-substance review: Analytical approaches in human sports drug testing. Drug Test. Anal. 2011, 3, 1.
7. M. Thevis, G. Sigmund, A. Koch, W. Schänzer . Determination of tuaminoheptane in doping control urine samples. Eur. J. Mass Spectrom. 2007, 13, 213.
8. R. Barrs . National Post. Canada, Taking Bad. Available at: http://www.canada.com/sports/baseball/Taking/7180056/story.html [6 December 2012].
9. A. Shipley . The Washington Post, Chemist's new product contains hidden substance. Available at: http://www.washingtonpost.com/wp-dyn/content/article/2006/05/07/AR2006050700913.html [25 April 2012].
10. C. Wilkins, P. Sweetsur . The impact of the prohibition of benzylpiperazine (BZP) 'legal highs' on the prevalence of BZP, new legal highs and other drug use in New Zealand. Drug Alcohol Depen. 2012, 127, 72.
11. Food and Drug Administration Notices. Withdrawal of approval of new drug applications. Fed. Reg. 1983, 48, 51425-604.
12. US Food and Drug Administration. FDA acts to remove ephedra-containing dietary supplements from market. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108379.htm [24 April 2012].
13. US Drug Enforcement Administration, US Department of Justice. Drugs of Abuse 2011 Edition; A DEA Resource Guide. Available at: http://www.justice.gov/dea/pr/multimedia-library/publications/drug_of_abuse.pdf [25 April 2012].
14. Y. Zhang, R.M. Woods, Z.S. Breitbach, D.W. Armstrong . 1, 3-dimethylamylamine (DMAA) in supplements and geranium products: Natural or synthetic? Drug Test. Anal. 2012, 4, 986.
15. M.J. Eliason, A. Eichner, A. Cancio, L. Bestervelt, B.D. Adams, P.A. Deuster . Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1, 3-dimethylamylamine (DMAA). Mil. Med. 2012, 177, 1455.
16. BBC News London, Claire Squires inquest: DMAA was a factor in marathon runner's death. Available at: http://www.bbc.co.uk/news/uk-england-london-21262717 [12 April 2013].
17. T.J. Tritten . Army probing connection between body building supplement, two deaths, Stars and Stripes. Available at: http://www.stripes.com/news/army-probing-connection-between-body-building-supplement-2-deaths-1.163652 [26 April 2012].
18. US FDA News Release. FDA challenges marketing of DMAA products for lack of safety evidence. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302133.htm [26 April 2013].
19. NMS Labs. Designer Drug Trends Report; Designer Drug Testing at NMS Labs. Available at: http://www.designerdrugtrends.org/documents/trendsreport2013_3.pdf [9 May 2013].
20. Army Bans DMAA Supplement. Available at: http://www.military.com/military-report/army-bans-dmaa-supplement [8 July 2013].
21. K. Overton . DMAA illegal for military members. Available at: http://www.pacaf.af.mil/news/story.asp?id=123345268 [15 July 2013].
22. FDA. Stimulant Potentially Dangerous to Health, FDA Warns. Available at: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM347700.pdf [15 July 2013].
23. A.G. Verstraete, F.V. Heyden . Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine. J. Anal. Toxicol. 2005, 29, 359.
24. J.M. Baron, D.A. Griggs, A.L. Nixon, W.H. Long, J.G. Flood . The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results. J. Anal. Toxicol. 2011, 35, 364.
25. J.T. Cody . Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results. J. Occup. Environ. Med. 2002, 44, 435.
26. Department of Defense. Office of the Under Secretary of Defense for Personnel and Readiness, Status of drug use in the Department of Defense personnel fiscal year 2011, Drug testing statistical report office. Available at: http://prhome.defense.gov/RFM/READINESS/DDRP/docs/6b%20FY%202011%20Annual%20Drug%20Use%20Status%20Report.pdf [29 May 2013].
27. Navy Personnel Command Public Affairs. Navy announces new drug testing parameters after year of record low positives. Available at: http://www.navy.mil/submit/display.asp?story_id=65775[12 May 2013].
28. WADA. Laboratory testing figures. Available at: http://www.wada-ama.org/en/Resources/Q-and-A/Laboratory-Testing-Figures 2011/ [30 May 2013].
29. R.B. Cody, J.A. Laramee, H.D. Durst . Versatile new ion source for the analysis of materials in open air under ambient conditions. Anal. Chem. 2005, 77, 2297.
30. R.B. Cody . Observation of molecular ions and analysis of nonpolar compounds with the direct analysis in real time ion source. Anal. Chem. 2008, 81, 1101.
31. R.G. Cooks, Z. Ouyang, Z. Takats, J.M. Wiseman . Ambient mass spectrometry. Science 2006, 311, 1566.
32. M.-Z. Huang, C.-H. Yuan, S.-C. Cheng, Y.-T. Cho, J. Shiea . Ambient ionization mass spectrometry. Annu. Rev. Anal. Chem. 2010, 3, 43.
33. T.J. Kauppila, A. Flink, M. Haapala, U.-M. Laakkonen, L. Aalberg, R.A. Ketola, R. Kostiainen . Desorption atmospheric pressure photoionization-mass spectrometry in routine analysis of confiscated drugs. Forensic Sci. Int. 2011, 210, 206.
34. N. Talaty, C.C. Mulligan, D.R. Justes, A.U. Jackson, R.J. Noll, R.G. Cooks . Fabric analysis by ambient mass spectrometry for explosives and drugs. Analyst 2008, 133, 1532.
35. G.J. Van Berkel, S.P. Pasilis, O. Ovchinnikova . Established and emerging atmospheric pressure surface sampling/ionization techniques for mass spectrometry. J. Mass Spectrom. 2008, 43, 1161.
36. M. Thevis, D.A. Volmer . Recent instrumental progress in mass spectrometry: Advancing resolution, accuracy, and speed of drug detection. Drug Test. Anal. 2012, 4, 242.
37. M. Thevis, T. Kuuranne, H. Geyer, W. Schänzer . Annual banned-substance review: Analytical approaches in human sports drug testing. Drug Test. Anal. 2012, 4, 2.
38. A.D. Lesiak, R.M. Musah, R.B. Cody, M.A. Domin, A.J. Dane, J.R.E. Shepard . Direct analysis in real time mass spectrometry (DART-MS) of "bath salt" cathinone drug mixtures. Analyst 2013, 138, 3424.
39. R.A. Musah, M.A. Domin, R.B. Cody, A.D. Lesiak, A. John Dane, J.R.E. Shepard . Direct analysis in real time mass spectrometry with collision-induced dissociation for structural analysis of synthetic cannabinoids. Rapid Commun. Mass Spectrom. 2012, 26, 2335.
40. I. Ojanperä, M. Kolmonen, A. Pelander . Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal. Bioanal. Chem. 2012, 403, 1203.
41. M. Higuchi, K. Saito . Rapid screening for synthetic cannabinoids and cathinones using direct analysis in real time (DART)-TOF-MS. Bunseki Kagaku 2012, 61, 705.
42. S.J.B. Dunham, P.D. Hooker, R.M. Hyde . Identification, extraction and quantification of the synthetic cannabinoid JWH-018 from commercially available herbal marijuana alternatives. Forensic Sci. Int. 2012, 223, 241.
43. R.A. Musah, M.A. Domin, M.A. Walling, J.R.E. Shepard . Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry. Rapid Commun. Mass Spectrom. 2012, 26, 1109.
44. M. Kawamura, R. Kikura-Hanajiri, Y. Goda . Simple and rapid screening for methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA) and their metabolites in urine using direct analysis in real time (DART)-TOFMS. Yakugaku Zasshi 2011, 131, 827.
45. A.T. Navare, J.G. Mayoral, M. Nouzova, F.G. Noriega, F.M. Fernández . Rapid direct analysis in real time (DART) mass spectrometric detection of juvenile hormone III and its terpene precursors. Anal. Bioanal. Chem. 2010, 398, 3005.
46. A.H. Grange, G.W. Sovocool . Detection of illicit drugs on surfaces using direct analysis in real time (DART) time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2011, 25, 1271.
47. R.R. Steiner, R.L. Larson . Validation of the direct analysis in real time source for use in forensic drug screening. J. Forensic Sci. 2009, 54, 617.
48. L. Perrenoud, M. Saugy, C. Saudan . Detection in urine of 4-methyl-2-hexaneamine, a doping agent. J. Chromatogr. B 2009, 877, 3767.
49. S. Yu, E. Crawford, J. Tice, B. Musselman, J.-T. Wu . Bioanalysis without sample cleanup or chromatography: The evaluation and initial implementation of direct analysis in real time ionization mass spectrometry for the quantification of drugs in biological matrixes. Anal. Chem. 2008, 81, 193.
50. J.D. Ropero-Miller, P.R. Stout . Forensic toxicology research and development evaluation of new and novel direct sample introduction, time of flight mass spectrometry (AccuTOF-DART) instrument for postmortem toxicology screening, final report. Award Number: 2006-DN-BX-K014, Document #224522. US Department of Justice, Office of Justice Programs, National Institute of Justice, Washington, D.C. 2008.
51. S.T. Ellison, W.E. Brewer, S.L. Morgan . Comprehensive analysis of drugs of abuse in urine using disposable pipette extraction. J. Anal. Toxicol. 2009, 33, 356.
52. WADA. Technical Document - TD2010MRPL; Minimum Required Performance Levels for Detection of Prohibited Substances. Available at: http://www.wada-ama.org/documents/world_anti-doping_program/wadp-is-laboratories/wada_td2010mrplv1.0_minimum%20required%20performance%20levels_sept%2001%202010_en.pdf [15 July 2013].
53. A. Roux, Y. Xu, J.-F. Heilier, M.-F. Olivier, E. Ezan, J.-C. Tabet, C. Junot . Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-orbitrap mass spectrometer. Anal. Chem. 2012, 84, 6429.
54. T. Zhang, D.J. Creek, M.P. Barrett, G. Blackburn, D.G. Watson . Evaluation of coupling reversed phase, aqueous normal phase, and hydrophilic interaction liquid chromatography with orbitrap mass spectrometry for metabolomic studies of human urine. Anal. Chem. 2012, 84, 1994.
55. J. Hsu, C. Liu, C.P. Hsu, W.-I. Tsay, J.-H. Li, D.-L. Lin, R.H. Liu . Performance characteristics of selected immunoassays for preliminary test of 3, 4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens. J. Anal. Toxicol. 2003, 27, 471.
56. P.R. Stout, K.L. Klette, R. Wiegand . Comparison and evaluation of dri® methamphetamine, dri ecstasy, abuscreen® online amphetamine, and a modified abuscreen online amphetamine screening immunoassays for the detection of amphetamine (amp), methamphetamine (mth), 3, 4-methylenedioxyamphetamine (mda) and 3, 4-methylenedioxymethamphetamine (mdma) in human urine. J. Anal. Toxicol. 2003, 27, 265.